Sat.Nov 19, 2022 - Fri.Nov 25, 2022

article thumbnail

Opinion: A tripledemic hurricane is making landfall. We need masks, not just tent hospitals

STAT

A viral hurricane is making landfall on health care systems battered by three pandemic years. With the official start of winter still weeks away, pediatric hospitals are facing crushing caseloads of children sick with RSV and other viral illnesses. Schools that promised a “return to normal” now report widespread absences and even closures from RSV and flu in many parts of the country , contributing to parents missing work in record numbers.

Hospitals 363
article thumbnail

The next era of Greater Boston’s biotech boom

PharmaVoice

How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth.

317
317
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medicines for Malaria Venture and Novartis move to phase 3 trial

Pharma Times

Ganaplacide/lumefantrinein new study as world faces emerging resistance to malaria treatments

150
150
article thumbnail

AI will continue to attract investment in near future in the healthcare industry

Pharmaceutical Technology

Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’. In this survey-based report tracker, digital media was prioritised as a top current investment target, with 53% of surveyed respondents confirming that their companies are currentl

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Real-world data show updated Covid-19 boosters increase protection against infection

STAT

The updated Covid-19 boosters increase people’s protection against symptomatic infection from the coronavirus, according to some of the first estimates of how the shot is performing in the real world and in people, not just in lab experiments. What’s more, that protection was even stronger when people waited a longer period of time since their last dose of the original shot.

Vaccines 341

More Trending

article thumbnail

Study brings personalised immunotherapy prescriptions closer

Pharma Times

Research showed that prescribing based solely on levels of proteins present is unlikely to be suitable

146
146
article thumbnail

First-in-human gene therapy trial for major cardiac syndrome

European Pharmaceutical Review

The first-in-human gene therapy trial for heart failure patients with preserved ejection fraction (HFpEF) has been approved by the US Food & Drug Administration (FDA). SRD-001, the adenovirus associated virus (AAV)-based gene therapy is delivered to cardiac ventricular muscle cells via an intracoronary infusion system (produced by Sardocor, a clinical-stage gene therapy subsidiary of Medera), to increase the protein expression and functional activity of sarcoplasmic reticulum calcium ATPase

Labelling 139
article thumbnail

STAT+: FDA approves a gene therapy for the inherited bleeding disorder hemophilia B

STAT

The Food and Drug Administration on Tuesday approved the first gene therapy to treat people with hemophilia B, an inherited bleeding disorder. The one-time treatment, called Hemgenix, was developed by the Dutch biotech company UniQure and will be marketed by CSL Behring, an Australian pharmaceutical company.

article thumbnail

In cancers with very low survival rates, Sellas aims higher

PharmaVoice

The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer.

264
264
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Turbine boosts AI platform to deliver cancer treatments

Pharma Times

€20m financing will focus on treatment pathways, new partnerships and team expansion

142
142
article thumbnail

FDA approves first gene therapy for Haemophilia B

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved Hemgenix (etranacogene dezaparvovec), the first gene therapy for adults with Haemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening haemorrhage, or have repeated, serious spontaneous bleeding episodes. Standard treatment for the condition involves replacing the missing or deficient clotting factor to improve the body’s ability to stop bleeding and promot

article thumbnail

Experimental flu vaccine, developed using mRNA, seen as potential game changer

STAT

An experimental influenza vaccine developed using messenger RNA technology appears capable of inducing what should be a protective immune response against all known subtypes of flu, at least in animals. If the work is translated into humans it could turn out to be a version of a long-sought universal vaccine. This would not be a vaccine that would block all flu infections, nor would it replace the need for an annual flu shot.

Vaccines 328
article thumbnail

Why the biopharma ‘IPO playbook’ changed in 2022

PharmaVoice

Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound.

264
264
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Takeda findings may minimise haemophilia treatment side effects

Pharma Times

Research from Takeda and Institute Krems Bioanalytics of IMC Krems and will help treat patients

142
142
article thumbnail

Taking the right forecasting approach for rare diseases

pharmaphorum

There are approximately 7,000 different types of rare disease and researchers estimate that there are more than 300 million people worldwide living with such a condition, according to the National Institutes of Health (NIH). However, only 5% of rare diseases are estimated to have at least one approved treatment, known as “orphan” therapies. A rare disease is any disease that affects a small percentage of the population.

Immunity 122
article thumbnail

Why doesn’t the U.S. have at-home flu tests?

STAT

Flu season is underway. RSV is putting record numbers of children in hospitals. And health professionals are gearing up for another Covid winter. With so many potential viruses in play, it would be helpful if Americans had a way to distinguish between different ailments at home. And when it comes to the flu in particular, at-home testing could help telehealth doctors decide when it makes sense to prescribe treatments like Paxlovid and Tamiflu, which need to be administered within a specific time

Hospitals 291
article thumbnail

Woman of the Week: Myriad Genetics’ Nicole Lambert

PharmaVoice

Empowered by her own cancer journey, Nicole Lambert is using her platform as chief operating officer of the genetic testing powerhouse to change the trajectory of care for millions of women.

130
130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Bristol Myers Squibb immunotherapy-chemo combination gets NICE recommendation

Pharma Times

Treatment involves adults with certain forms of advanced stomach and oesophageal cancer

137
137
article thumbnail

Ex-Theranos CEO Elizabeth Holmes sentenced to 11 years

pharmaphorum

Elizabeth Holmes, the founder and former chief executive of blood testing biotech Theranos, has been sentenced after being convicted of defrauding investors in the company earlier this year, receiving a prison sentence of more than 11 years in a California court. That’s shorter than the 15 years sought by prosecutors, but considerably longer than the 18 months’ house arrest that Holmes’ defense attorneys had pushed for, and there is likely to be an appeal against the sentence,

122
122
article thumbnail

How infectious disease experts are responding to Covid nearly three years in

STAT

The world is fast approaching the third anniversary of those days when we got our first inkling that a new disease was spreading in China. In the months that followed, normal life was suspended, then upended. At this point, everyone is well and truly sick of Covid-19 and the accommodations we have had to make to co-exist with it. So sick of it, in fact, that many people appear to have given up trying to avoid the SARS-CoV-2 virus.

262
262
article thumbnail

Executive changes at Teva, Eversana could spell commercial growth in the new year

PharmaVoice

With their latest personnel moves, these life sciences companies are preparing for major business shifts.

130
130
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Storm doses first patient with solid tumour drug candidate

Pharma Times

Candidate is first molecule targeting an RNA methyltransferase enzyme to enter development

137
137
article thumbnail

Using UHPLC-MS/MS for trace detection of ?-lactam antibiotics

European Pharmaceutical Review

A paper, published in Molecules , has developed validated the use of ultra-performance liquid chromatography with triple quadrupole mass spectrometry, or UHPLC-MS/MS, for identification and detection of the ?-lactams cephapirin and ceftiofur in cleaning solutions of the production reactors. Trace detection of ?-lactam antibiotics in cleaning rinse solutions and manufacturing aids in pharmaceutical facilities is crucial and regulated.

article thumbnail

STAT+: UPMC, Advocate Aurora, Duke fighting lawsuits over use of Meta’s tracking tool

STAT

Five months after a media investigation revealed that hospitals were feeding Meta sensitive patient information through a tracking tool on their websites, prominent systems like UPMC, Advocate Aurora, and Duke Health are still contending with the resulting legal action. The Markup and STAT News co-published an investigation in June that found one-third of Newsweek’s top 100 U.S. hospitals were using a tracker called Meta Pixel that sends Meta, formerly known as Facebook, data whenever pat

Hospitals 257
article thumbnail

Can a formal needs assessment simplify Speaker Bureau compliance?

PharmaVoice

In the biopharmaceutical industry, phases of innovation and change are often driven by regulatory action.

130
130
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.